Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes

NCT ID: NCT06583798

Last Updated: 2024-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

33 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anatomical and Visual outcomes of retinal re-surgeries done in silicone oil filled eyes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Basic demographic profile including Name, Age, Gender, Place of Residence will be documented.
* structured questionnaire will be used to collect information regarding systemic diseases including Diabetes mellitus and its duration, Hypertension, Dyslipidemia , any cardiovascular diseases, any history of ocular trauma or any other ocular comorbidities.
* Details of the primary retinal surgery including indication, date of surgery, Name of the procedure will be noted
* Details of re surgery including indication (retinal pathology), timing of the re surgery from the primary surgery, preoperative Best Corrected Visual Acuity(BCVA) A using log MAR (Minimum Angle of resolution)) chart at 3 meters, intra ocular pressure using non contact Reichert 7 tonometry will be noted.
* Slit lamp bio-microscopy of the anterior segment using Topcon slit lamp biomicroscope,90 Diopter lens examination and indirect ophthalmoscopy with 20 Diopter lens of the fundus will be done.
* Spectral domain OCT(Optical coherence Tomography) with Zeiss Cirrus HD OCT (High Definition- Optical Coherence tomography) machine will be done for documentation of the status of macula in whichever cases possible.
* Re surgery will be done by a single Senior consultant in all the cases. Alcon Luxor Biomicroscope with Non contact BIOM (binocular indirect ophthalmomicroscope ) viewing system will be used. 2 ports will be made. Top up of Silicone oil will be done whenever needed. Membrane peeling with relaxing retinectomy / drainage retinotomy , haemostasis and endolaser will be done under Silicone oil as required. After the re surgery, the patient will be advised to maintain prone position.
* After the re surgery the BCVA(Best Corrected Visual Acuity), IOP (Intraocular pressure) will be noted on first visit at 15 days, 3rd month and 6th month follow up.
* Fundus examination will be done at all visits. Spectral Domain OCT(Optical coherence Tomography) will be done at all visits to see the status of macula.

STATISTICAL ANALYSIS

* Data entry will be done in Microsoft excel and analysed using the latest SPSS (Statistical Package for the Social Sciences) software.
* Wherever required, descriptive analysis will be done
* Chi square test will be used to find the statistical significance among the qualitative data, •two-tail t test will be used to find statistical significance among the quantitative data pre and post operatively.
* Other statistical tests will be used depending upon the need for post hoc analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Detachment Proliferative Vitreo-Retinopathy Proliferative Diabetic Retinopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resurgery In Silicone Oil Filled Eyes

* Alcon Luxor Biomicroscope with Non-contact BIOM (binocular indirect ophthalmomicroscope) viewing system was used.
* 2 ports were made in Pars plana.
* Top up of Silicone oil was done whenever needed.
* Membrane peeling with relaxing retinectomy / drainage retinotomy, haemostasis and endolaser were done under Silicone oil as required.
* After the re surgery, the patients were advised to maintain prone position.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who had under gone the primary retina surgery at Ahalia Foundation Eye Hospital / elsewhere for retinal detachment secondary to various retinal pathologies and underwent re surgery during their follow up at Ahalia Foundation Eye Hospital during the study period.
* Patients whose proper follow up to 6 months after re surgery were maintained during the study period.
* No history of any additional eye disease other than h/o cataract surgery or primary RD repair.
* Patients who were willing to be a part of the study and willing to provide informed written consent.

Exclusion Criteria

* Patients who did not come for any of the follow up included in the study.
* Patients who had history of ocular trauma after the primary surgery.
* Patients who have any other ocular comorbidities other than cataract.
* Patients who had undergone multiple previous re surgeries for retinal detachment.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ahalia Foundation Eye Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Saurav Mahajan

Principal Investigator, Clinical Professor Adjunct

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rajkumar Maheshwari, MS

Role: PRINCIPAL_INVESTIGATOR

Ahalia Foundation Eye Hospital

C R Asla Jahan, DNB

Role: PRINCIPAL_INVESTIGATOR

Ahalia Foundation Eye Hospital

Saurav Mahajan, MS

Role: PRINCIPAL_INVESTIGATOR

Ahalia Foundation Eye Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahaliafoundation Eye Hospital

Palakkad, Kerala, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1312-4448

Identifier Type: OTHER

Identifier Source: secondary_id

TP232602676

Identifier Type: OTHER

Identifier Source: secondary_id

202201.

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.